Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessCompaniesDr Reddy's launches generic Allegra drug in US

    Dr Reddy's launches generic Allegra drug in US

    Having won a legal tussle, Dr Reddy's Laboratories on Thursday finally launched its generic Allegra tablets, Fexofenadine HCl, in the US market. DRL will market the over-the-counter product under store brand labels in the US market.

    April 15, 2011 / 12:32 IST

    Having won a legal tussle, Dr Reddy's Laboratories on Thursday finally launched its generic Allegra tablets, Fexofenadine HCl, in the US market. DRL will market the over-the-counter product under store brand labels in the US market.

    In June last year, French drug maker Sanofi Aventis, which also sells the anti-allergy drug Allegra, had obtained a court injunction against DRL launching Allegra-D24, based on grounds of patent infringement.

    But this year, a US District Court and the US FDA both gave the green signal to India's second-biggest drug maker, to go ahead with the US launch of the product.

    first published: Apr 15, 2011 08:53 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347